Massively parallel CRISPR off-target detection enables rapid off-target prediction model building.

[1]  Zheng Hu,et al.  FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity , 2022, Nature Communications.

[2]  Suchita P. Nety,et al.  The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases , 2021, Science.

[3]  E. Koonin,et al.  Programmable RNA targeting with the single-protein CRISPR effector Cas7-11 , 2021, Nature.

[4]  Ciaran M Lee,et al.  Tools for experimental and computational analyses of off-target editing by programmable nucleases , 2020, Nature Protocols.

[5]  A. Kernytsky,et al.  Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods , 2020, The CRISPR journal.

[6]  J. Sagartz,et al.  CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice , 2020, Molecular therapy. Methods & clinical development.

[7]  P. Debata,et al.  An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapy , 2020, EBioMedicine.

[8]  Ruochi Zhang,et al.  CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity , 2020, Nature Biotechnology.

[9]  Zhaolei Zhang,et al.  CRISPR‐Net: A Recurrent Convolutional Network Quantifies CRISPR Off‐Target Activities with Mismatches and Indels , 2020, Advanced Science.

[10]  Wen Xue,et al.  Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases , 2020, Theranostics.

[11]  Dipali G. Sashital,et al.  CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects , 2020, The Journal of Biological Chemistry.

[12]  P. Debata,et al.  Hyperbranched poly(β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Stan J. J. Brouns,et al.  Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants , 2019, Nature Reviews Microbiology.

[14]  Luca Pinello,et al.  CRISPRitz: rapid, high-throughput and variant-aware in silico off-target site identification for CRISPR genome editing , 2019, Bioinform..

[15]  Michael P Snyder,et al.  Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements , 2019, Nature Communications.

[16]  Xiangdong Wang,et al.  Off-target genome editing: A new discipline of gene science and a new class of medicine , 2019, Cell Biology and Toxicology.

[17]  Emanuel J. V. Gonçalves,et al.  Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens , 2019, Nature.

[18]  You Lu,et al.  Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research , 2019, Molecular therapy. Methods & clinical development.

[19]  F. Bushman,et al.  iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity , 2019, Genome Biology.

[20]  Charles D. Yeh,et al.  Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq , 2018, Science.

[21]  Daesik Kim,et al.  DIG-seq: a genome-wide CRISPR off-target profiling method using chromatin DNA , 2018, Genome research.

[22]  Tyler J. Reich,et al.  Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells , 2018, Nature.

[23]  Tao Zhang,et al.  CRISPRMatch: An Automatic Calculation and Visualization Tool for High-throughput CRISPR Genome-editing Data Analysis , 2018, International journal of biological sciences.

[24]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[25]  R. Weiss,et al.  Human oncogenic viruses: nature and discovery , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[26]  A. Bassuk,et al.  Unexpected mutations after CRISPR–Cas9 editing in vivo , 2017, Nature Methods.

[27]  J. Joung,et al.  CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets , 2017, Nature Methods.

[28]  Erik L. G. Wernersson,et al.  BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks , 2017, Nature Communications.

[29]  Leslie S. Edwards,et al.  Mapping the genomic landscape of CRISPR–Cas9 cleavage , 2017, Nature Methods.

[30]  J. Doudna,et al.  Cornerstones of CRISPR–Cas in drug discovery and therapy , 2016, Nature Reviews Drug Discovery.

[31]  Jin-Wu Nam,et al.  In vivo high-throughput profiling of CRISPR–Cpf1 activity , 2016, Nature Methods.

[32]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.

[33]  Jin-Soo Kim,et al.  Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells , 2016, Nature Biotechnology.

[34]  Martin J. Aryee,et al.  Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells , 2016, Nature Biotechnology.

[35]  Max A. Horlbeck,et al.  Nucleosomes impede Cas9 access to DNA in vivo and in vitro , 2016, eLife.

[36]  Jin-Soo Kim,et al.  Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq , 2016, Genome research.

[37]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[38]  Xiao-Hui Zhang,et al.  Off-target Effects in CRISPR/Cas9-mediated Genome Engineering , 2015, Molecular therapy. Nucleic acids.

[39]  A. Regev,et al.  Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System , 2015, Cell.

[40]  Honglin Chen,et al.  CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells. , 2015, The Journal of general virology.

[41]  Changyu Wang,et al.  TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy. , 2015, The Journal of clinical investigation.

[42]  Martin J. Aryee,et al.  GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.

[43]  Akash Kumar,et al.  MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing , 2014, Bioinform..

[44]  M. Rowicka,et al.  Nucleotide-resolution DNA double-strand breaks mapping by next-generation sequencing , 2013, Nature Methods.

[45]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[46]  C. Wheeler,et al.  HPV genotypes: implications for worldwide cervical cancer screening and vaccination. , 2010, The Lancet. Oncology.

[47]  Alexander A. Sousa,et al.  Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs , 2017, Nature Biomedical Engineering.

[48]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..

[49]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..